EGFR and breast adenocarcinoma: It has been recently reported that the TLK1 paralog, TLK2, could form a complex with Src and activate the EGFR/Src/FAK signaling pathway to promote the migration and invasion of breast adenocarcinoma and glioblastoma cells [19,20].